Patents by Inventor Nicholas Kallan

Nicholas Kallan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
    Publication number: 20080058327
    Abstract: The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
    Type: Application
    Filed: July 5, 2007
    Publication date: March 6, 2008
    Inventors: Ian Mitchell, James Blake, Rui Xu, Nicholas Kallan, Dengming Xiao, Keith Spencer, Josef Bencsik, Eli Wallace, Stephen Schlachter, Anna Banka, Jun Liang, Brian Safina, Jun Li, Christine Chabot
  • HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
    Publication number: 20080051399
    Abstract: The present invention provides compounds, including resolved enantiomers, resolved diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula I: Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
    Type: Application
    Filed: July 5, 2007
    Publication date: February 28, 2008
    Inventors: Ian Mitchell, James Blake, Rui Xu, Nicholas Kallan, Dengming Xiao, Keith Spencer, Josef Bencsik, Eli Wallace, Stephen Schlachter, Anna Banka, Jun Liang, Brian Safina, Birong Zhang, Christine Chabot, Steven Do
  • AKT protein kinase inhibitors
    Publication number: 20050130954
    Abstract: The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
    Type: Application
    Filed: November 19, 2004
    Publication date: June 16, 2005
    Inventors: Ian Mitchell, Keith Spencer, Peter Stengel, Yongxin Han, Nicholas Kallan, Mark Munson, Guy Vigers, James Blake, Anthony Piscopio, John Josey, Scott Miller, Dengming Xiao, Riu Xu, Chang Rao, Bin Wang, April Bernacki